SCHEMBL19084698

SCHEMBL19084698

O=C(Nc1cc(C(=O)O)ccc1N1CCOCC1)OCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 7/20 0.67
MAOA P21397 7/20 0.67
KDM1B Q8NB78 7/20 0.67
RCOR1 Q9UKL0 7/20 0.67
MAOB P27338 5/20 0.67
ALDH1A1 P00352 9/20 0.60
POLB P06746 1/20 0.55
TSHR P16473 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
PRKDC P78527 1/20 0.51
KMT2A Q03164 1/20 0.50
F10 P00742 1/20 0.50
KDM4E B2RXH2 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
GAA P10253 1/20 0.48
LMNA P02545 1/20 0.48
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15777298 0.92 KDM1A (0.68) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL19084607 0.89 KDM1A (0.66) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL17302737 0.88 KDM1A (0.61) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL15777281 0.87 KDM1A (0.67) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL28808690 0.86 ALDH1A1 (0.67) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL17287400 0.81 KDM1A (1.00) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL17287398 0.81 KDM1A (1.00) KDM1AMAOAKDM1BRCOR1MAOB
Hydrochloric Acid SCHEMBL17287370 0.81 KDM1A (1.00) KDM1AMAOAKDM1BRCOR1MAOB
Hydrochloric Acid SCHEMBL17287369 0.81 KDM1A (1.00) KDM1AMAOAKDM1BRCOR1MAOB
SCHEMBL22335151 0.79 KDM1A (0.81) KDM1AMAOAKDM1BRCOR1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10233165-B2 Cyclopropylamine compounds as histone demethylase inhibitors ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2019-03-19 US disclosed
US-20170190680-A1 CYCLOPROPYLAMINE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS IEO - ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2017-07-06 US disclosed
US-20170190680-A1 CYCLOPROPYLAMINE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS IEO - ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10233165-B2 Cyclopropylamine compounds as histone demethylase inhibitors KDM1B, PHF2, KDM6B KDM1A 12/4885MAOA 439/4885KDM1B 1/4885
US-20170190680-A1 CYCLOPROPYLAMINE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, PHF2, KDM6B KDM1A 12/4885MAOA 439/4885KDM1B 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.